Periprocedural management of antithrombotics is a common but challenging clinical scenario that renders patients vulnerable to potential adverse events such as bleeding and thrombosis. Over the past decade, periprocedural antithrombotic approaches have changed considerably with the advent of direct oral anticoagulants (DOACs), as well as a paradigm shift away from bridging in many warfarin patients. Successfully navigating this high-risk period relies on a number of individualized patient assessments conducted within a framework of standardized, systematic approaches. It also requires a thorough understanding of antithrombotic pharmacokinetics, multidisciplinary coordination of care, and comprehensive patient education and empowerment. In this article, we provide clinicians with a practical, stepwise approach to periprocedural management of antithrombotic agents through case-based examples of relevant clinical scenarios.
CITATION STYLE
Burnett, A. E., Ragheb, B., & Kaatz, S. (2021). Perioperative consultative hematology: can you clear my patient for a procedure? Hematology (United States), 2021(1), 521–528. https://doi.org/10.1182/hematology.2021000287
Mendeley helps you to discover research relevant for your work.